Matinas Biopharma Holdings Inc.

Matinas Biopharma Holdings Inc. (MTNB) is a United States-based biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of serious diseases. The company leverages its proprietary Lipid Nano-Crystal (LNC) platform technology to develop differentiated product candidates designed to improve the intracellular delivery of drugs, potentially leading to enhanced efficacy and reduced toxicity. Matinas Biopharma's research and development efforts are primarily centered on addressing unmet medical needs in areas such as infectious diseases, cardiovascular health, and oncology. By utilizing its LNC technology, the company aims to create orally administered formulations of drugs that are currently limited by their delivery methods or bioavailability. Matinas Biopharma is committed to advancing its pipeline of product candidates through clinical development and ultimately delivering impactful therapies to patients.